(Q39561115)

English

Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus

scientific article published on April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus (English)

1 reference

Europe PubMed Central

13 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

13 September 2017

author name string

Zhi-Yun Zhao

2

1 reference

Europe PubMed Central

13 September 2017

Yan-Ping Li

3

1 reference

Europe PubMed Central

13 September 2017

Yu-Ping Wang

4

1 reference

Europe PubMed Central

13 September 2017

Lan-Hu Hao

5

1 reference

Europe PubMed Central

13 September 2017

Bo Fan

6

1 reference

Europe PubMed Central

13 September 2017

Yu-Huan Li

7

1 reference

Europe PubMed Central

13 September 2017

Yue-Ming Wang

8

1 reference

Europe PubMed Central

13 September 2017

Yong-Qiang Shan

9

1 reference

Europe PubMed Central

13 September 2017

Yan-Xing Han

10

1 reference

Europe PubMed Central

13 September 2017

Yan-Ping Zhu

11

1 reference

Europe PubMed Central

13 September 2017

Jian-Rui Li

12

1 reference

Europe PubMed Central

13 September 2017

Xue-Fu You

13

1 reference

Europe PubMed Central

13 September 2017

Zhuo-Rong Li

14

1 reference

Europe PubMed Central

13 September 2017

Jian-Dong Jiang

15

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

53

1 reference

Europe PubMed Central

13 September 2017

4

1 reference

Europe PubMed Central

13 September 2017

1080-1089

1 reference

Europe PubMed Central

13 September 2017

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

APOBEC3G inhibits elongation of HIV-1 reverse transcripts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Small-molecule inhibition of HIV-1 Vif.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

APOBEC3G targets human T-cell leukemia virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Real-time RT-PCR for quantitation of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

The interaction between HIV-1 Gag and APOBEC3G.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Enhancing immunity to HIV through APOBEC.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Viral hepatitis in HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

APOBEC-mediated viral restriction: not simply editing?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Antiviral potency of APOBEC proteins does not correlate with cytidine deamination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

APOBEC3G & HTLV-1: inhibition without deamination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Interferon-based therapy for chronic hepatitis C: current and future perspectives

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Antiviral resistance and specifically targeted therapy for HCV (STAT-C).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Identification of HCV protease inhibitor resistance mutations by selection pressure-based method

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

High expression of APOBEC3G in patients infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24160

21 January 2018

Identifiers

10.1002/HEP.24160

1 reference

Europe PubMed Central

13 September 2017

release_irggwsdp6rglzedpmbvml2p25e

0 references

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39561115&oldid=1839994109"